Bioconnect Systems, Inc. is pioneering novel surgical implants and
techniques that form precisely controlled vascular connections.
The Optiflow™ family of sutureless anastomotic connectors provides
a fast and repeatable method for connecting vessels.
While the technology is applicable to a wide range of surgical procedures, Bioconnect is initially focused on improving vascular access in End Stage Renal Disease (ESRD) patients who undergo hemodialysis. There are over two million patients suffering from ESRD. The American Society of Nephrology and the US Renal Data System have called ESRD a “worldwide plague.”
Optiflow™ is an investigational device in the United States and not available for sale.